| Date Filed | Type | Description |
| 08/16/2023 |
4
| Thunen Shelley B (Director) has filed a Form 4 on AEON Biopharma, Inc.|
Txns:
| Granted 58,851 options
@ $5.47, valued at
$321.9k
|
|
| 07/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/10/2023 |
4
| Thunen Shelley B (CFO) has filed a Form 4 on RxSight, Inc.|
Txns:
| Granted 120,000 options to buy
@ $14.95, valued at
$1.8M
|
|
| 08/02/2021 |
4
| Thunen Shelley B (CFO) has filed a Form 4 on RxSight, Inc.|
Txns:
| Granted 98,367 options to buy
@ $16, valued at
$1.6M
|
|
| 07/29/2021 |
3
| Thunen Shelley B (CFO) has filed a Form 3 on RxSight, Inc. |
| 06/15/2018 |
4
| Thunen Shelley B (Director) has filed a Form 4 on Restoration Robotics, Inc.|
Txns:
| Granted 13,708 options to buy
@ $2.89, valued at
$39.6k
|
|
| 10/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/21/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/26/2015 |
4
| Thunen Shelley B (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 2,537 shares
@ $0
Paid exercise price by delivering 954 shares
@ $16.45, valued at
$15.7k
|
|
| 03/02/2015 |
4
| Thunen Shelley B (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 3,820 shares
@ $0
Paid exercise price by delivering 1,673 shares
@ $15.77, valued at
$26.4k
|
|
| 05/27/2014 |
4
| Thunen Shelley B (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 7,593 shares
@ $0
Granted 19,084 options to buy
@ $13.17, valued at
$251.3k
|
|
| 03/13/2014 |
4
| Thunen Shelley B (CFO) has filed a Form 4 on ENDOLOGIX INC /DE/|
Txns:
| Granted 40,000 shares
@ $0
Paid exercise price by delivering 2,384 shares
@ $13.85, valued at
$33k
|
|
| 01/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2013 |
3
| Thunen Shelley B (CFO) has filed a Form 3 on ENDOLOGIX INC /DE/ |